Handbook/Tissue Repair & Healing/BPC-157 + TB-500 Combo (10mg+10mg)

BPC-157 + TB-500 Combo (10mg+10mg)

Featured

Also known as: BPC/TB Stack 10mg, Healing Duo 10mg, High-Dose Healing Stack

A higher-dose pre-mixed combination of BPC-157 and TB-500 for extended healing protocols.

Overview

This higher-dose combination contains 10mg each of BPC-157 and TB-500, providing more doses per vial for extended healing protocols or those preferring higher individual doses. Same mechanisms as the 5mg combo but with more total peptide per vial.

Mechanism of Action

Same as 5mg combo: BPC-157 promotes angiogenesis and tissue repair; TB-500 enhances cell migration and reduces inflammation. Combined for comprehensive healing.

Pharmacokinetics

Same as individual components. More total peptide per vial for extended use.

Dosing Protocols

Note: These are research protocols from literature. This is not medical advice.

1

Extended Healing

Dose

250-500 mcg each

Frequency

Daily or 5 days/week

Duration

8-12 weeks

More doses per vial

Stacking Recommendations

Peptides that may be combined based on complementary mechanisms in research settings.

Rationale: Additional healing

Synergy: Third healing pathway

Research Areas

Extended HealingChronic InjuriesComprehensive RepairAthletic Recovery

Key Research Findings

  • 1Higher total dose per vial
  • 2Cost-effective for extended protocols
  • 3Same mechanisms as lower-dose combo
  • 4Popular for serious healing needs

Side Effects & Contraindications

Reported Side Effects

  • Injection site reactions
  • Headache (rare)
  • Fatigue

Contraindications

  • Active cancer (theoretical)
  • Recent surgery (wait for MD clearance)

Safety Considerations

Same as 5mg combo. Research compounds. Individual dosing still applies - this is just more total peptide per vial.

Storage Requirements

Refrigerate 2-8°C after reconstitution

Scientific References

Quick Reference

Sequence
Combination product
Molecular Weight
Variable
Half-Life
Variable by component
Bioavailability
Injectable
Research Stage
preclinical
Administration
Subcutaneous injection